Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
A Cornell University study estimates a 6% average drop in spending within six months of GLP-1 use, which grows to 9% for higher-income households
December 24, 2024.
PlexusDx recommends pairing injections with behavioral coaching rather than extreme restriction
By examining the latest research findings and clinical insights, we aim to provide clinicians, researchers, and patients alike with a deeper understanding of this evolving therapeutic landscape
An exploratory DEXA substudy of the STEP 1 trial (140 participants, 68 weeks) found that semaglutide 2.4 mg produced a 19.3% reduction in total fat mass and a 9.7% reduction in total lean body mass with the proportion of lean mass relative to total body mass actually increasing by 3.0 percentage points because fat was lost more rapidly. These results were exploratory and not corrected for statistical multiplicity, so they should be interpreted accordingly
Patients can opt for convenient home sample collection supported by 10,000+ touchpoints, with quick turnaround times and stringent quality controls for reliable results
